LFMD
Get informed when a big investor buys or sells
+ Follow| Market cap | $224.40 Million |
|---|---|
| Enterprise Value | $208.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.23 |
| Beta | 1.99 |
| Outstanding Shares | 47,336,060 |
| P/E Ratio | -11.26 |
|---|---|
| PEG | 1.41 |
| Price to Sales | 1.5 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.26 |
| Enterprise Value to EBIT | -10.87 |
| Enterprise Value to Net Income | 56 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 1.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 67.65% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.39%▼ 37.74% |
|---|---|
| Total Invested | $762,691▼ 98.82% |
| Investors Holding | 4▼ 103.00% |
No data
LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordab...